Table 4.
Summary of those 3 genome-wide gene expression datasets involving HP patients.
| HP | Control | |||||||
|---|---|---|---|---|---|---|---|---|
| GSE No. | Sample number (HP/Control) | Ages(mean±sd) | Sex(M/F) | Ages(mean±sd) | Sex(M/F) | Type of HP | Platform | Authors |
| GSE47460 | 30/108 | 57±11.09 | 9/21 | 63.62±11.35 | 49/59 | NA | GPL6480 and GPL14550 | Kim et al |
| GSE150910 | 82/103 | 59.4±10.6 | 39/43 | 59.9±10.2 | 44/56 | CHP | Illumina Nova Seq 6000 | Furusawa et al |
| GSE135893 | 3/10 | NA | NA | NA | NA | CHP | Illumina NextSeq 500, Illumina HiSeq 4000, Illumina NovaSeq 6000 |
Habermann et al |
CHP, Chronic Hypersensitivity Pneumonitis; NA, not applicable; M, Male; F, Female.